Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nasdaq Biotechnology Ishares ETF
(NQ:
IBB
)
147.80
+2.95 (+2.04%)
Official Closing Price
Updated: 4:15 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nasdaq Biotechnology Ishares ETF
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Did ARKK Bottom?
July 05, 2022
ARKK may be the most extraordinary example of sheer brilliance and horrific money management combined.
Via
Talk Markets
3 Biotech Stocks to Sell Now
July 05, 2022
These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.
Via
InvestorPlace
The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study
July 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Something Still Smells. Actions You Should Take Now!
July 03, 2022
In June alone, the S&P 500, the Dow, the Nasdaq 100, and the Small-Cap indices were all down over 8% for the month. It wasn't pretty. Fortunately, it's halftime, and this can create an opportunity for...
Via
Talk Markets
What’s Next For Biotech And Healthcare
June 13, 2022
Biotechs have sold off this year along with the broader market. Declines have been more pronounced than prior pullbacks. However, healthcare continues to outperform.
Via
Talk Markets
Growth and Inflation Fears May Have Peaked: Top Trading Opportunities
July 01, 2022
As bad as US equity markets have been in 2022, Chinese equity markets have had it much worse since early 2021.
Via
Talk Markets
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
July 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
July 01, 2022
The biotech sector is poised to end June on a positive note, despite largely disappointing regulatory decisions scheduled during the month, thanks to a reversal in broader market sentiment.
Via
Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
June 30, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Post PCE-What is the Pre-PCE Market Saying?
June 29, 2022
Stocks are primarily unchanged or trading slightly higher as pressures from rising food and energy prices persist.
Via
Talk Markets
The Daily Biotech Pulse: Eli Lilly Modifies COVID-19 Treatment Pact, Oyster Point Outlines Restructuring Plan, Icosavax Posts Interim RSV Vaccine Data
June 29, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Kezar Life Surges On Positive Kidney Disease Trial Data, FDA Rejects Spero Therapeutics' Tebipenem, Graybug Reviews Strategic Alternatives
June 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Flu Shots Can Cut Down Risk Of Alzheimer's, Exploratory Study Finds
June 28, 2022
Alzheimer's is a tough neurological disease to tackle, given the difficulty in diagnosing at an early stage, and the limited and effective treatment options currently available.
Via
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Biotech Stocks With Key Catalysts Coming in July
June 27, 2022
Biotech stocks have had a rocky few months, but many are on the mend. These picks should provide investors both flexibility and growth.
Via
InvestorPlace
The Daily Biotech Pulse: European Backing For Novavax's COVID-19 Shot In Adolescents, Sanofi-GSK's Updated Vaccine Effective Against Omicron, FDA's Clinical Hold On Sarepta's Duchenne Trial
June 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
June 23, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Are We Heading Towards Recession?
June 22, 2022
Transportation, as the ultimate demand indicator, could also help us determine the fate of recession.
Via
Talk Markets
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Demand Destruction as Seen in the Transportation Sector
June 21, 2022
Transportation IYT opened higher, ran to its 200-week moving average, and retreated, albeit whilst remaining green on the day.
Via
Talk Markets
The Daily Biotech Pulse: Thumbs Down For Acadia's Pimavanserin, Pfizer Buys Stake In Valneva, AstraZeneca - Ionis Eplontersen Aces Rare Disease Trial
June 21, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
A Moment Of Truth - Ways To Help You Deal With A New Reality
June 19, 2022
The truth can be difficult to hear. This week, investors had to deal with a heavy dose of truth about the state of the economy. Based on the markets’ response, it was painfully unexpected and...
Via
Talk Markets
The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease
June 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Can the Fed Control Inflation with Higher Rates?
June 15, 2022
Today’s rally in equities might be met with further selling very soon once the market realizes that the Fed cannot go far enough.
Via
Talk Markets
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
June 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
For Signs of a Relief Rally, Watch the S&P 500 v. Retail
June 14, 2022
With inflation on everyone’s lips and the price of gas and food showing no signs of abating, the retail sector is the key to assessing where the equity market goes from here.
Via
Talk Markets
The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
June 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why This Biotech ETF May Be About to Break Out
June 09, 2022
There’s a chance shares of the iShares Biotechnology ETF (NASDAQ: IBB) may be about to break out. They are testing a resistance level. If they can get above it, a new uptrend may form.
Via
Benzinga
Watch For The Nasdaq 100 and S&P 500 to Clear Their Mini Ranges
June 08, 2022
As the current leader of the major indices, IWM has been playing a very important role in the overall market direction.
Via
Talk Markets
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.